Barr Laboratory BRL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Barr Laboratory BRL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: harkenman who wrote (80)	10/24/1997 11:52:00 AM
From: James Silverman	Read Replies (1) of 207

Actually it was 0.47 vs 0.08 when excluding a charge. The stock held up well in the face of a lousy day and remember it broke below $35 recently. The results looked very nice to me: $7M payment on Cipro settlement, if this is a regular quarterly payment the stock has a serious floor under it, $17M in initial Warfarin sales, including 150,000 filled prescriptions. The rampup looked better than I had been expecting. Looks like earning can get to several dollars a share next year. Its a quiet company, so maybe another quarter or two like this one and the stock will test old highs.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next